RET Gene RET Selective Sequencing of Exons 5
SDHD Gene Paraganglioma and Gastric Stromal Sarcoma Genetic Test sale cost 4400 AED SDHD Gene Paraganglioma and Gastric Stromal Sarcoma Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Cancer Targeted Gene Panel CNS Tumor Test sale cost 4680 AED Cancer Targeted Gene Panel CNS Tumor Test Cost 5,200 د.إ Original price was: 5,200 د.إ.4,680 د.إCurrent price is: 4,680 د.إ.
Sale!

RET Gene RET Selective Sequencing of Exons 5, 8, 10, 11, and 13-16 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The RET Gene RET Selective Sequencing of Exons 5, 8, 10, 11, and 13-16 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations within specific exons of the RET gene that are commonly associated with various hereditary cancer syndromes, including Multiple Endocrine Neoplasia type 2 (MEN2) and Medullary Thyroid Carcinoma (MTC). By focusing on exons 5, 8, 10, 11, and 13-16, this test aims to provide a targeted approach in the genetic evaluation of individuals at risk for these conditions, facilitating early detection and the implementation of preventive or therapeutic measures. The test is priced at 4400 AED, reflecting the intricate process of selective exon sequencing and the comprehensive analysis required to ensure accurate results. Conducted at the state-of-the-art facilities of DNA Labs UAE, patients can expect a reliable service grounded in scientific expertise and cutting-edge genetic technology.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

RET Gene RET Selective Sequencing of Exons 5 8 10 11 and 13-16 Genetic Test

Welcome to DNA Labs UAE, your trusted genetic lab for advanced DNA testing. Today, we will be discussing the RET Gene RET selective sequencing of exons 5, 8, 10, 11, and 13-16 genetic test. This test is crucial for the diagnosis and management of genetic disorders such as multiple endocrine neoplasia type 2 (MEN2) and familial medullary thyroid carcinoma (FMTC).

Test Name: RET Gene RET Selective Sequencing of Exons 5 8 10 11 and 13-16 Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Cancer

Doctor: Oncologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for RET Gene RET selective sequencing of exons 5, 8, 10, 11, and 13-16 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with RET Gene RET selective sequencing of exons 5, 8, 10, 11, and 13-16 NGS Genetic DNA Test gene RET

Test Details

The RET gene, also known as the rearranged during transfection gene, is a proto-oncogene that codes for a receptor tyrosine kinase involved in cell growth and development. Mutations in the RET gene have been associated with several genetic disorders, including multiple endocrine neoplasia type 2 (MEN2) and familial medullary thyroid carcinoma (FMTC).

Selective sequencing of specific exons of the RET gene, such as exons 5, 8, 10, 11, and 13-16, is a type of genetic test known as next-generation sequencing (NGS). NGS allows for the simultaneous sequencing of multiple genes or regions of interest, providing a comprehensive analysis of genetic variations. By targeting these specific exons, the NGS genetic test can identify mutations or variants within the RET gene that may be associated with MEN2 or FMTC.

These mutations can help diagnose individuals at risk of developing these disorders or guide treatment decisions. Overall, the selective sequencing of exons 5, 8, 10, 11, and 13-16 of the RET gene using NGS is a valuable tool in the genetic testing of individuals suspected to have MEN2 or FMTC, allowing for early detection, risk assessment, and personalized management of these genetic disorders.

Test Name RET Gene RET selective sequencing of exons 5 8 10 11 and 13-16 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cancer
Doctor Oncologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for RET Gene RET, selective sequencing of exons 5, 8, 10, 11 and 13-16 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with RET Gene RET, selective sequencing of exons 5, 8, 10, 11 and 13-16 NGS Genetic DNA Test gene RET
Test Details

The RET gene, also known as the rearranged during transfection gene, is a proto-oncogene that codes for a receptor tyrosine kinase involved in cell growth and development. Mutations in the RET gene have been associated with several genetic disorders, including multiple endocrine neoplasia type 2 (MEN2) and familial medullary thyroid carcinoma (FMTC).

Selective sequencing of specific exons of the RET gene, such as exons 5, 8, 10, 11, and 13-16, is a type of genetic test known as next-generation sequencing (NGS). NGS allows for the simultaneous sequencing of multiple genes or regions of interest, providing a comprehensive analysis of genetic variations.

By targeting these specific exons, the NGS genetic test can identify mutations or variants within the RET gene that may be associated with MEN2 or FMTC. These mutations can help diagnose individuals at risk of developing these disorders or guide treatment decisions.

Overall, the selective sequencing of exons 5, 8, 10, 11, and 13-16 of the RET gene using NGS is a valuable tool in the genetic testing of individuals suspected to have MEN2 or FMTC, allowing for early detection, risk assessment, and personalized management of these genetic disorders.

SKU: TEST-4578 Category:

Related products